Found 121 matching trials
Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscore PHASE2 This is a single-arm, open-label, multi-center clinical study to evaluate t...
Show More Location
Nanfang Hospital, Southern Medical University
Learn More & Join Trial
Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer PHASE2 Rectal cancer still remains one of the most popular tumors, however, distan...
Show More Location
Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences,
Learn More & Join Trial
Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer PHASE2 This study is a single-center, prospective, open-label, randomized controll...
Show More Location
Fourth Hospital of Hebei Medical University
Learn More & Join Trial
A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer PHASE2 This study is a prospective phase II clinical trial aimed at exploring the ...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management PHASE2 The study is designed to test the hypothesis that patients with Locally adv...
Show More Status
Active Not Recruiting
Location
University of California, Irvine
Learn More & Join Trial
Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer N/A This is a multicenter, randomized, controlled phase III trial to evaluate t...
Show More Location
Department of Radiation Oncology, Shandong Cancer Hospital and Institute
Learn More & Join Trial
Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer PHASE1 The median survival time of first-line chemotherapy for advanced gastric ca...
Show More Learn More & Join Trial
SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer. PHASE2 SBRT Combined with CAPEOX, Bevacizumab, and PD-1 Inhibitor in RAS-Mutant, M...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer NA Colorectal cancer is the fourth most common cancer in China. Up to 30% of p...
Show More Location
Beijing Chaoyang Hospital, Capital Medical University
Learn More & Join Trial
Clinical Study of Apatinib Combined With Second - Line Chemotherapy for Metastatic Colorectal Cancer PHASE2 (1) Evaluate the efficacy of apatinib in combination with standard second-l...
Show More Location
Multiple Locations
Learn More & Join Trial